# Bracco Diagnostics, Inc. – FDA Inspection, Nov 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/d8ae4b2a-425e-4deb-b9cc-7fb2caafb3cd
Source feed: FDA_Inspections

> FDA inspection 1235540 of Bracco Diagnostics, Inc., November 27, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235540
- Company Name: Bracco Diagnostics, Inc.
- Inspection Date: 2024-11-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1012798 - 2017-06-05](https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/e0991274-2562-4845-8b64-817cf7ec9a23)
- [FDA Inspection 888857 - 2014-05-30](https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/7372a10c-dbb4-4372-9b1e-0aec12879c71)
- [FDA Inspection 837980 - 2013-06-13](https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/714d2364-c60a-4f76-b077-a99988f35c2a)
- [FDA Inspection 792085 - 2012-07-27](https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/41a9a0a8-8b28-48be-bfab-381103266f66)
- [FDA Inspection 773087 - 2012-03-08](https://www.keypedia.com/records/fda_inspections/bracco-diagnostics-inc/5c13b901-d48d-429c-a1ec-c2ac514b3648)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/bracco-diagnostics-inc/ba89d169-e267-4c3a-845a-6440dc422aec

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
